APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dipeptide Peptidase 4 (DPP-4) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis and Forecast 2026-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchDipeptide Peptidase 4 (DPP-4) Inhibitors Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Dipeptide Peptidase 4 (DPP-4) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dipeptide Peptidase 4 (DPP-4) Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dipeptide Peptidase 4 (DPP-4) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dipeptide Peptidase 4 (DPP-4) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dipeptide Peptidase 4 (DPP-4) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dipeptide Peptidase 4 (DPP-4) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dipeptide Peptidase 4 (DPP-4) Inhibitors include Takeda Pharmaceutical Company, Merck, Eli Lilly, Boehringer Ingelheim, BMS and AstraZenica, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dipeptide Peptidase 4 (DPP-4) Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dipeptide Peptidase 4 (DPP-4) Inhibitors, also provides the sales of main regions and countries. Of the upcoming market potential for Dipeptide Peptidase 4 (DPP-4) Inhibitors, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dipeptide Peptidase 4 (DPP-4) Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dipeptide Peptidase 4 (DPP-4) Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dipeptide Peptidase 4 (DPP-4) Inhibitors sales, projected growth trends, production technology, application and end-user industry.

Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Company

Takeda Pharmaceutical Company

Merck

Eli Lilly

Boehringer Ingelheim

BMS

AstraZenica

Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Type

Alogliptin

Linagliptin

Sitagliptin

Saxagliptin

Vildagliptin

Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Application

Hospitals

Clinics

Dipeptide Peptidase 4 (DPP-4) Inhibitors Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dipeptide Peptidase 4 (DPP-4) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dipeptide Peptidase 4 (DPP-4) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dipeptide Peptidase 4 (DPP-4) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dipeptide Peptidase 4 (DPP-4) Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dipeptide Peptidase 4 (DPP-4) Inhibitors sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Alogliptin Major Manufacturers Table 3. Linagliptin Major Manufacturers Table 4. Sitagliptin Major Manufacturers Table 5. Saxagliptin Major Manufacturers Table 6. Vildagliptin Major Manufacturers Table 7. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals Major Manufacturers Table 9. Clinics Major Manufacturers Table 10. Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Trends Table 11. Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Drivers Table 12. Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Opportunities and Challenges Table 13. Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Restraints Table 14. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2021-2026) Table 18. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2027-2032) Table 19. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2021-2026) & (K Units) Table 21. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2027-2032) & (K Units) Table 22. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2021-2026) Table 23. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2027-2032) Table 24. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 28. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers, Product Type & Application Table 32. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2021-2026) Table 39. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2027-2032) Table 40. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 42. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 43. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2021-2026) Table 44. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2027-2032) Table 45. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 46. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 47. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2021-2026) Table 51. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2027-2032) Table 52. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 54. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 55. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2021-2026) Table 56. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2027-2032) Table 57. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 58. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 59. Takeda Pharmaceutical Company Company Information Table 60. Takeda Pharmaceutical Company Business Overview Table 61. Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio Table 63. Takeda Pharmaceutical Company Recent Development Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio Table 68. Merck Recent Development Table 69. Eli Lilly Company Information Table 70. Eli Lilly Business Overview Table 71. Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio Table 73. Eli Lilly Recent Development Table 74. Boehringer Ingelheim Company Information Table 75. Boehringer Ingelheim Business Overview Table 76. Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio Table 78. Boehringer Ingelheim Recent Development Table 79. BMS Company Information Table 80. BMS Business Overview Table 81. BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio Table 83. BMS Recent Development Table 84. AstraZenica Company Information Table 85. AstraZenica Business Overview Table 86. AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio Table 88. AstraZenica Recent Development Table 89. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 92. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 93. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 94. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 95. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 96. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 97. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 98. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 99. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 100. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 101. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 105. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 106. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 107. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 108. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 109. United States Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 110. Canada Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 111. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 114. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 115. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 116. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 117. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 120. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 121. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 122. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 123. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 127. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 128. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 129. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 130. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 131. Germany Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 132. France Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 133. U.K. Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 134. Italy Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 135. Netherlands Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 136. Nordic Countries Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 137. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 138. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 139. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 140. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 141. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 142. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 143. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 144. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 145. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 146. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 147. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 148. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 150. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 151. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 152. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 153. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 154. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 155. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 158. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 159. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 160. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 165. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 166. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 167. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 168. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 169. Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 170. South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 171. India Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 172. Australia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 173. China Taiwan Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 174. Southeast Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 175. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 176. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 177. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2026) & (K Units) Table 178. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2027-2032) & (K Units) Table 179. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 180. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 181. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 182. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 183. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2026) & (K Units) Table 184. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2027-2032) & (K Units) Table 185. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 186. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 187. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 191. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021-2026) & (K Units) Table 192. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2027-2032) & (K Units) Table 193. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 194. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 195. Brazil Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 196. Argentina Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 197. Chile Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 198. Colombia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 199. Peru Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 200. Saudi Arabia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 201. Israel Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 202. UAE Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 203. Turkey Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 204. Iran Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 205. Egypt Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors List Table 209. Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Dipeptide Peptidase 4 (DPP-4) Inhibitors Image Figure 2. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 4. Alogliptin Image Figure 5. Linagliptin Image Figure 6. Sitagliptin Image Figure 7. Saxagliptin Image Figure 8. Vildagliptin Image Figure 9. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (2021-2032) & (US$ Million) Figure 15. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2021-2032) Figure 18. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales (2021-2032) & (K Units) Figure 19. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales YoY (2021-2032) & (K Units) Figure 22. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales YoY (2021-2032) & (K Units) Figure 23. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales YoY (2021-2032) & (K Units) Figure 26. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2021-2032) Figure 32. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2021-2032) Figure 35. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2021-2032) Figure 38. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2021-2032) Figure 41. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Type (2021-2032) Figure 42. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Type (2021-2032) Figure 43. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Application (2021-2032) Figure 44. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Application (2021-2032) Figure 45. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Country (2021-2032) Figure 46. North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Country (2021-2032) Figure 47. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Type (2021-2032) Figure 48. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Type (2021-2032) Figure 49. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Application (2021-2032) Figure 50. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Application (2021-2032) Figure 51. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Country (2021-2032) Figure 52. Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Country (2021-2032) Figure 53. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Type (2021-2032) Figure 54. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Type (2021-2032) Figure 55. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Application (2021-2032) Figure 56. China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Application (2021-2032) Figure 57. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Type (2021-2032) Figure 58. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Type (2021-2032) Figure 59. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Application (2021-2032) Figure 60. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Application (2021-2032) Figure 61. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Country (2021-2032) Figure 62. Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Country (2021-2032) Figure 63. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Type (2021-2032) Figure 64. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Type (2021-2032) Figure 65. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Application (2021-2032) Figure 66. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Application (2021-2032) Figure 67. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Share by Country (2021-2032) Figure 68. SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Share by Country (2021-2032) Figure 69. Dipeptide Peptidase 4 (DPP-4) Inhibitors Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Alogliptin
  • Linagliptin
  • Sitagliptin
  • Saxagliptin
  • Vildagliptin
Applications
  • Hospitals
  • Clinics
Companies covered
  • Takeda Pharmaceutical Company
  • Merck
  • Eli Lilly
  • Boehringer Ingelheim
  • BMS
  • AstraZenica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market by Type
  3. 1.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Alogliptin
  5. 1.2.3 Linagliptin
  6. 1.2.4 Sitagliptin
  7. 1.2.5 Saxagliptin
  8. 1.2.6 Vildagliptin
  9. 1.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market by Application
  10. 1.3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Clinics
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Dynamics
  1. 2.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Trends
  2. 2.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Drivers
  3. 2.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Opportunities and Challenges
  4. 2.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region
  3. 3.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2021-2026)
  5. 3.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Region (2027-2032)
  6. 3.2.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region
  9. 3.4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2021-2026)
  11. 3.4.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Region (2027-2032)
  12. 3.4.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Manufacturers
  2. 4.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Manufacturers
  6. 4.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers, Product Type & Application
  13. 4.7 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market CR5 and HHI
  16. 4.8.2 2025 Dipeptide Peptidase 4 (DPP-4) Inhibitors Tier 1, Tier 2, and Tier 3
5 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market by Type
  1. 5.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type
  2. 5.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type
  6. 5.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type
6 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market by Application
  1. 6.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application
  2. 6.1.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application
  6. 6.2.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceutical Company
  2. 7.1.1 Takeda Pharmaceutical Company Company Information
  3. 7.1.2 Takeda Pharmaceutical Company Business Overview
  4. 7.1.3 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
  6. 7.1.5 Takeda Pharmaceutical Company Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Boehringer Ingelheim
  20. 7.4.1 Boehringer Ingelheim Company Information
  21. 7.4.2 Boehringer Ingelheim Business Overview
  22. 7.4.3 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
  24. 7.4.5 Boehringer Ingelheim Recent Developments
  25. 7.5 BMS
  26. 7.5.1 BMS Company Information
  27. 7.5.2 BMS Business Overview
  28. 7.5.3 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
  30. 7.5.5 BMS Recent Developments
  31. 7.6 AstraZenica
  32. 7.6.1 AstraZenica Company Information
  33. 7.6.2 AstraZenica Business Overview
  34. 7.6.3 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product Portfolio
  36. 7.6.5 AstraZenica Recent Developments
8 North America
  1. 8.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Type
  2. 8.1.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  3. 8.1.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  4. 8.1.3 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2021-2032)
  5. 8.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Application
  6. 8.2.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  7. 8.2.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 8.2.3 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2021-2032)
  9. 8.3 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country
  10. 8.3.1 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Type
  2. 9.1.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  4. 9.1.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2021-2032)
  5. 9.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Application
  6. 9.2.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 9.2.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2021-2032)
  9. 9.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country
  10. 9.3.1 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Type
  2. 10.1.1 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  3. 10.1.2 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  4. 10.1.3 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2021-2032)
  5. 10.2 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Application
  6. 10.2.1 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  7. 10.2.2 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 10.2.3 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Type
  2. 11.1.1 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  4. 11.1.3 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2021-2032)
  5. 11.2 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Application
  6. 11.2.1 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 11.2.3 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2021-2032)
  9. 11.3 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country
  10. 11.3.1 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Type
  2. 12.1.1 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Type (2021-2032)
  5. 12.2 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Application
  6. 12.2.1 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Application (2021-2032)
  9. 12.3 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size by Country
  10. 12.3.1 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dipeptide Peptidase 4 (DPP-4) Inhibitors Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Value Chain Analysis
  2. 13.1.1 Dipeptide Peptidase 4 (DPP-4) Inhibitors Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Production Mode & Process
  6. 13.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Distributors
  9. 13.2.3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst